BioSig Technologies (NASDAQ:BSGM) appointed Samuel Navarro as an independent director.
Mr. Navarro has more than 30 years of experience in investment banking and medical technology. He is the managing partner of Gravitas Healthcare, a strategic advisory firm specializing in medical device companies.
Mr. Navarro began his career as a senior medical research analyst at UBS Securities, Furman Selz and Needham & Company. He then served as global head of healthcare investment banking at ING Barings, senior portfolio manager at The Galleon Group and, most recently, as a managing director and global head of medical technology investment banking at Cowen & Company.
Mr. Navarro serves, or has served on, the boards of other medical device companies including Arstasis, Derma Sciences, Dextera Surgical, Fixes-4-Kids, Jomed, MicroTherapeutics, and StrataSkin Sciences (NASDAQ:SSKN).
“Sam’s accomplishments in both investment banking and particularly the medical device space are second-to-none, and we are honored that he is able to join us as our new independent director,” Kenneth Londoner, chairman and CEO of BioSig, said in a statement.
“His experience adds more weight to the already impressive collective skillset of our board, and we look forward to Sam’s contributions as we continue to execute on our core goals and objectives,” he added.
